Day 1
Monday, September 14, 2026
Opening Remarks
Rakesh Jain
10:00-10:10 am
Tumor Microenvironment I: Angiogenesis and Vascular Function
Rakesh Jain
10:10-11:20 am
Q&A
Rakesh Jain
11:20-11:35 am
Break
11:35-11:50 am
Tumor Microenvironment II: Vascular Normalization and Immunotherapy
Rakesh Jain
11:50 am-1:10 pm
Q&A
Rakesh Jain
1:10-1:25 pm
Break
1:25-2:00 pm
Tumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis
Rakesh Jain
2:00-3:20 pm
Q&A
Rakesh Jain
3:20-3:35 pm
Break
3:35-4:05 pm
Cancer Immunology and Immunotherapy Overview
Arlene Sharpe
4:05-5:10 pm
Q&A
Arlene Sharpe
5:10-5:25 pm
Day 2
Tuesday, September 15, 2026
Circadian Clock and Metabolic Vulnerabilities of Cancer
Chi Dang
10:00-11:05 am
Q&A
Chi Dang
11:05-11:20 am
Break
11:20-11:50 am
Skull Bone Marrow as a Site for Immuno-Surveillance of Healthy Brain and Brain
Jonathan Kipnis
11:50 am-12:55 pm
Q&A
Jonathan Kipnis
12:55-1:10 pm
Break
1:10-2:10 pm
Determinants of How Tumors Use Metabolism to Support Growth
Matthew Vander Heiden
2:10-3:15 pm
Q&A
Matthew Vander Heiden
3:15-3:30 pm
Break
3:30-4:00 pm
Emerging Strategies to Improve CAR-T cell Therapy for Glibolastoma and other Solid Tumors
Hideho Okada
4:00-5:05 pm
Q&A
Hideho Okada
5:05-5:20 pm
Day 3
Wednesday, September 16, 2026
AI in Basic and Clinical Oncology
Eliezer Van Allen
10:00-11:05 am
Q&A
Eliezer Van Allen
11:05-11:20 am
Break
11:20-11:50 am
Dissecting the Ecosystem of Gliomas by Single-Cell and Spatial Genomics
Mario Suva
11:50 am-12:55 pm
Q&A
Mario Suva
12:55-1:10 pm
Break
1:10-2:10 pm
Identifying Immune Vulnerabilities in Solid Tumors
Lisa Coussens
2:10-3:15 pm
Q&A
Lisa Coussens
3:15-3:30 pm
Break
3:30-4:00 pm
Whispering in the Forset: How Pediatric Brain Tumors Converse with their Microenvironment
Robert Wechsler-Reya
4:00-5:05 pm
Q&A
Robert Wechsler-Reya
5:05-5:20 pm
Day 4
Thursday, September 17, 2026
Mechanisms of the Gut Microbiome from Biomarker to Immunotherapy Adjuvant
Bertrand Routy
10:00-11:05 am
Q&A
Bertrand Routy
11:05-11:20 am
Break
11:20-11:50 am
Metastasis Ecosystems
Joan Massague
11:50 am-12:55 pm
Q&A
Joan Massague
12:55-1:10 pm
Break
1:10-2:10 pm
Fibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer
David Tuveson
2:10-3:15 pm
Q&A
David Tuveson
3:15-3:30 pm
Break
3:30-4:00 pm
Neural Influences on Primary and Metastatic Brain Tumors
Michelle Monje
4:00-5:05 pm
Q&A
Michelle Monje
5:05-5:20 pm
Summary and Closing Remarks
5:20-5:30 pm